Connor, Clark & Lunn Investment Management (CC&L)’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,100	Closed	-$62K	–	931
2015 Q4	$62K	Buy	+10,100	New	+$62K	﹤0.01%	779
2015 Q1	–	Sell	-24,300	Closed	-$184K	–	634
2014 Q4	$184K	Buy	+24,300	New	+$184K	﹤0.01%	532